The molecular etiology and treatment of glucocorticoid-induced osteoporosis

Glucocorticoid-induced osteoporosis (GIOP) is the most common form of secondary osteoporosis, accounting for 20% of osteoporosis diagnoses. Using glucocorticoids for >6 months leads to osteoporosis in 50% of patients, resulting in an increased risk of fracture and death. Osteoblasts, osteocytes,...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Cheng-Huan, Lin, Wen-Ying, Yeh, Kuang-Ting, Chen, Ing-Ho, Wu, Wen-Tien, Lin, Ming-Der
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323641/
https://www.ncbi.nlm.nih.gov/pubmed/34386357
http://dx.doi.org/10.4103/tcmj.tcmj_233_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323641/
https://www.ncbi.nlm.nih.gov/pubmed/34386357
http://dx.doi.org/10.4103/tcmj.tcmj_233_20

Ejemplares similares